Structured Exercise Improves Survival in Stage II/III Colon Cancer

A structured exercise program after adjuvant chemotherapy in patients with high-risk stage II or III colon cancer ...

JUNE 16, 2025

Topical Gel Relieves Painful Rash Caused by Anti-EGFR Therapies

A novel topical gel significantly reduced the severity of the acne-like rash, a common side effect of ...

JUNE 13, 2025

FDA Approves Opdivo With Yervoy for Unresectable or Metastatic MSI-H or dMMR Colorectal Cancer

The FDA has approved Opdivo with Yervoy for unresectable or metastatic microsatellite instability−high or ...

APRIL 9, 2025

FDA Approves Lumakras With Vectibix for KRAS G12C–Mutated Colorectal Cancer

The FDA has approved Lumakras with Vectibix for adult patients with KRAS G12C–mutated metastatic colorectal ...

JANUARY 21, 2025

FDA Approves Opdivo Qvantig for Subcutaneous Injection

The FDA approved nivolumab plus hyaluronidase-nvhy (Opdivo Qvantig, Bristol Myers Squibb) for subcutaneous ...

DECEMBER 30, 2024

Pharmacists Help Apply PGx Tests In Gastro Settings

A new pilot study suggests that pharmacogenomics testing may help clinicians avoid toxicities in patients with ...

MAY 8, 2018

Opdivo Receives New Indication for MSI-H or dMMR Colorectal Cancer

The FDA granted a new indication to Opdivo for the treatment of patients aged 12 years and older with mismatch ...

AUGUST 2, 2017

An Aspirin a Day Keeps CVD and CRC At Bay

The U.S. Preventive Services Task Force issued recommendations based on age and risk for the use of aspirin for ...

APRIL 13, 2016